SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-062735
Filing Date
2011-11-09
Accepted
2011-11-09 16:32:15
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a11-25863_110q.htm 10-Q 1122995
2 EX-31.1 a11-25863_1ex31d1.htm EX-31.1 11749
3 EX-31.2 a11-25863_1ex31d2.htm EX-31.2 11743
4 EX-32.1 a11-25863_1ex32d1.htm EX-32.1 6262
5 EX-32.2 a11-25863_1ex32d2.htm EX-32.2 6267
  Complete submission text file 0001104659-11-062735.txt   4105088

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT irwd-20110930.xml EX-101.INS 566473
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT irwd-20110930.xsd EX-101.SCH 16308
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT irwd-20110930_cal.xml EX-101.CAL 48417
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT irwd-20110930_lab.xml EX-101.LAB 289643
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT irwd-20110930_pre.xml EX-101.PRE 136601
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT irwd-20110930_def.xml EX-101.DEF 111075
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 111192075
SIC: 2834 Pharmaceutical Preparations